Amicus Therapeutics Inc. buy Citigroup Inc.
Start price
17.12.25
/
50%
€9.40
Target price
17.12.26
€14.47
Performance (%)
31.60%
Price
27.04.26
€12.34
Summary
This prediction is currently active. With a performance of 31.60% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 17.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | - | - |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat